Eva Hoess

USPTO Granted Patents = 16 (Patent Applications = 2)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 5.6

ph-index = 5

Forward Citations = 122(Granted Patents)

Location History:

Starnberg, DE (1996 - 2001)
Munich, DE (2003 - 2011)
Neuried, DE (2015 - 2023)

Company Filing History:

5 out of 1,648

Roche Diagnostics Operations, Inc.

patents

4 out of 1,164

Boehringer Mannheim Gmbh

patents

3 out of 480

Roche Diagnostics Gmbh

patents

4. 3 out of 4,942

Hoffmann-la Roche Inc.

patents

5. 1 out of 2

Eucodis Bioscience Gmbh

patents

Years Active: 1996-2023

where 'Filed Patents' based on already Granted Patents

16 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11796540 - Methods for modulating signal intensity in interaction assays (2023-10-24),

2. 9587006 - IGF-I poly (ethylene glycol) conjugates (2017-03-07),

3. 8927230 - C-terminal modification of polypeptides (2015-01-06),

4. 7897404 - Conjugates of defined stoichiometry (2011-03-01),

5. 7476727 - Conjugates of mycophenolic acid (2009-01-13),

6. 7348423 - Nucleic acids encoding fusion peptides (2008-03-25),

7. 7235675 - Conjugates of mycophenolic acid (2007-06-26),

8. 6858410 - Process for making antifusogenic fusion peptides that form inclusion bodies (2005-02-22),

9. 6811998 - Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase (2004-11-02),

10. 6593079 - Method for simultaneous detection of HIV antigens and HIV antibodies (2003-07-15),

11. 6524808 - Enzyme inhibition immunoassay (2003-02-25),

12. 6210901 - Specific binding substances for antibodies and their use for immunoassays or vaccines (2001-04-03),

13. 5601824 - Homobidental, trifunctional linkers used in immunologically active (1997-02-11),

14. 5573922 - Immunological detection method for triazines (1996-11-12),

15. 5519142 - Homobidental, trifunctional linkers, method for their preparation and (1996-05-21),

Title: Innovations by Eva Hoess

Introduction

Eva Hoess is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, holding a total of 16 patents. Her work focuses on methods and devices that enhance the accuracy and efficiency of interaction assays.

Latest Patents

Among her latest patents, one notable invention is a method for modulating signal intensity in interaction assays. This method involves determining an analyte in a sample by contacting it with an interaction modulator, which can include various compounds such as Poly-(4-styrenesulfonic acid-co-maleic acid) and aminodextran. Another significant patent involves IGF-I poly (ethylene glycol) conjugates, detailing a method for producing a polypeptide conjugated to poly (ethylene glycol) through a series of precise steps involving nucleic acid expression and peptide conjugation.

Career Highlights

Eva has worked with renowned companies in the biotechnology sector, including Roche Diagnostics Operations, Inc. and Boehringer Mannheim GmbH. Her experience in these organizations has allowed her to develop innovative solutions that address complex challenges in the field.

Collaborations

Throughout her career, Eva has collaborated with notable colleagues such as Erasmus Huber and Christine Markert-Hahn. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Eva Hoess is a distinguished inventor whose work has significantly impacted the biotechnology industry. Her innovative patents and collaborations reflect her commitment to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.